Bamboo Therapeutics, Inc. — Form D/A
Bamboo Therapeutics, Inc. of CHAPEL HILL, NC, a company, filed a Form D amendment with the SEC on 2016-02-11. The offering totals $49.5M, of which $49.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-02-11
- Form: D/A
- Accession: 0001666110-16-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $49.5M
- Amount sold: $49.5M
- Minimum investment: $300K
- Investors: 6
- Date of first sale: 2016-01-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-257284
Issuer
- Name: Bamboo Therapeutics, Inc.
- CIK: 0001666110
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 870 MARTIN LUTHER KING, JR. BLVD., CHAPEL HILL, NC, 27514
- Phone: 919-942-0252
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michael Jude Goettler | Director | Chapel Hill, NC |
| Sheila Mikhail | Director | Durham, NC |
| Richard Jude Samulski | Director | Chapel Hill, NC |
| Robert Jude Smith | Director | Chapel Hill, NC |
| Sheila Mikhail | Executive Officer | Durham, NC |
| Richard Jude Samulski | Executive Officer | Chapel Hill, NC |
Other filings by this issuer (1)
More